双侧新生血管性年龄相关性黄斑变性五年发病率与视力结局
第二受累眼基线视力优于第一眼,但5年治疗后视力下降5.8个ETDRS字母,第一眼保持稳定,且第二眼注射次数更少、再激活更早。5年第二眼累及累积发病率为54%。
要点
- 第二受累眼5年视力下降5.8个字母,第一眼保持稳定。
- 第二眼年注射次数少于第一眼(6.2 vs 7.8次/年)。
- 第二眼再激活更早(376 vs 507天),5年累及累积发病率54%。
核心结论
- 第二受累眼接受更少治疗且再激活更早,5年视力下降而第一眼稳定,应避免治疗不足。
研究设计与样本
- 前瞻性设计登记数据库(Fight Retinal Blindness!项目)分析,覆盖澳大利亚、新西兰、瑞士和新加坡的真实世界结局。
主要发现
- 第二受累眼基线平均视力显著高于第一眼(20/50+2 vs 20/80;P<0.01)。
- 第二眼5年治疗平均丢失5.8个logMAR字母(-9.1至-2.6),第一眼视力稳定(P=0.01)。
- 治疗第一年后第二眼年注射次数少于第一眼(6.2 vs 7.8;P<0.01),再激活更早(376 vs 507天;P=0.04)。
- 5年第二眼累及累积发病率为54%。
临床怎么用
- 对第二受累眼应保持与第一眼相当的治疗强度,避免治疗不足。
- 第二眼再激活更早,需加强随访监测以及时发现并处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare treatment intensity and mean visual acuity gains for first- and second-affected eyes with age-related macular degeneration nAMD over 5 years of treatment. The cumulative incidence of second-eye involvement was assessed. METHOD: We analyzed data from the Fight Retinal Blindness! project database, a prospectively designed registry of "real-world" outcomes from Australia, New Zealand, Switzerland, and Singapore. Patients with bilateral age-related macular degeneration with ≥5 years of follow-up on treatment were included. RESULTS: Six thousand five hundred and forty-two eyes being treated for age-related macular degeneration were tracked from 2005 to 2017. Thousand two hundred and sixty-one patients had bilateral age-related macular degeneration; of whom, 302 had 5 years of follow-up. Of these, 170 patients started treatment for each eye at least 2 months apart. The mean baseline visual acuity of second-affected eyes was significantly higher than that of first-eyes (20/50 + 2 vs. 20/80; P < 0.01). Second-affected eyes lost a mean of 5.8 (-9.1 to -2.6) logarithm of the minimum angle of resolution letters after 5 years of treatment, whereas the vision of the first-affected eyes remained stable (P = 0.01). Second-affected eyes received fewer injections than the first-affected eyes after the first year of treatment (6.2/year vs. 7.8/year; P < 0.01) and reactivated earlier (376 vs. 507 days; P = 0.04). The cumulative incidence of second eye involvement was 54% over 5 years. CONCLUSION: Second-affected eyes received fewer treatments and reactivated earlier. Care should be taken to avoid undertreating second-affected eyes.
引用
- Cornish EE, Teo KY, Nguyen V, et al. FIVE-YEAR INCIDENCE AND VISUAL ACUITY OUTCOMES FOR INTRAVITREAL THERAPY IN BILATERAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fight Retinal Blindness! Project. Retina. 2021. PMID: 32310628. doi:10.1097/IAE.0000000000002798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。